Published in Pharma Law Weekly, January 11th, 2005
At the same time, Centocor, Inc., said it is adding a new label warning about possible liver damage from the pharmaceutical, which is also used in the treatment of rheumatoid arthritis and Crohn's disease. Centocor is a unit of Johnson & Johnson.
Ankylosing spondylitis is a progressive inflammatory condition that can result in fusion of the spine and damage to hips and other joints.
It usually affects people under age 35. The Spondylitis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly